Brief: Candel Therapeutics Inc Names Jason Amello As Chief Financial Officer
07/09/2022 13:08
Sept 7 (Reuters) - Candel Therapeutics Inc CADL.O :
* CANDEL THERAPEUTICS INC - JASON A. AMELLO JOINS CANDEL AS
CHIEF
FINANCIAL OFFICER
* CANDEL THERAPEUTICS INC - AMELLO IS JOINING CANDEL
EFFECTIVE
SEPTEMBER 21, 2022, AND IS REPLACING JOHN CANEPA, CANDEL'S
CURRENT CFO
Source text for Eikon: ID:nGNX6ZcRVC
Further company coverage: CADL.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints In Patients From Phase 3 Trial Of Aglatimagene Besadenovec (Can-2409)
Candel Therapeutics reports Q1 loss
Brief: Candel Therapeutics Q1 Net Income USD -8.861 Million
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Candel Therapeutics Inc Extended Survival Tail Observed In Trial Of Aglatimagene Besadenovec